Roche has dropped five Chugai…
Roche has dropped five Chugai candidates from its clinical pipeline, [...]
Recorded at Fierce Biotech Week,…
Recorded at Fierce Biotech Week, this episode of “The Top [...]
Moderna is halting development of…
Moderna is halting development of an mRNA vaccine for congenital [...]
In a mixed interim data drop,…
In a mixed interim data drop, Arcturus Therapeutics has revealed [...]
Alector Therapeutics is shelving a…
Alector Therapeutics is shelving a GSK-partnered antibody after the asset [...]
With $70 million and a phase 2…
With $70 million and a phase 2 ready asset in [...]
“We need to pick a lane here as…
“We need to pick a lane here as a country. [...]
GSK and Spero Therapeutics have…
GSK and Spero Therapeutics have shared phase 3 results on [...]
After rejecting Replimune’s…
After rejecting Replimune’s melanoma drug RP1 this summer, the FDA [...]
The U.S. private equity market is…
The U.S. private equity market is showing signs of recovery, [...]